{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:07:28Z","timestamp":1781626048898,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005716","name":"Babol University of Medical Sciences","doi-asserted-by":"publisher","award":["724134858"],"award-info":[{"award-number":["724134858"]}],"id":[{"id":"10.13039\/501100005716","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bladder cancer is a prevalent urothelial cancer, and recent studies have focused on the potential role of Human Papillomavirus (HPV) in its development. This study investigates the prevalence and viral load of HPV types 16 and 18 in bladder urothelial neoplasms and compares these findings with non-neoplastic samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cross-sectional study was conducted using tissue samples from patients with urothelial bladder carcinoma (UBC) and a non-neoplastic control group. DNA was extracted and analyzed using real-time PCR to detect and quantify HPV types 16 and 18.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Although the prevalence of high-risk HPV types (16 and 18) was higher in bladder cancer patients compared to controls, the difference was not statistically significant. However, HPV-16 viral load was significantly higher in patients (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), and HPV-18 viral load was also significantly elevated (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.004). Both HPV-16 and HPV-18 viral loads were generally higher in bladder cancer patients compared to healthy individuals.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study demonstrated an increased prevalence of high-risk HPV types in bladder urothelial neoplasms, with elevated viral loads for HPV-16 and HPV-18 in the cancer group. While these differences were not statistically significant, the increased viral load suggests that HPV may play a role in bladder cancer progression, particularly in cases of persistent infection. These findings highlight the importance of strengthening HPV vaccination programs and further investigation into the long-term effects of HPV on bladder cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13027-025-00725-4","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T14:45:16Z","timestamp":1766501116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human papillomavirus type 16 and 18 in urothelial bladder neoplasms: detection, quantification, and comparison with non-neoplastic samples"],"prefix":"10.1186","volume":"21","author":[{"given":"Arshia","family":"Yazdani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghodsieh","family":"Kamrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arefeh Ebrahimian","family":"Shiadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emadoddin","family":"Moudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Vosough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Shirafkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzin","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akramossadat","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"725_CR1","doi-asserted-by":"crossref","unstructured":"Zhang Y, Rumgay H, Li M, Yu H, Pan H, Ni J. The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040. J Global Health. 2023;13.","DOI":"10.7189\/jogh.13.04109"},{"issue":"9","key":"725_CR2","doi-asserted-by":"publisher","first-page":"7867","DOI":"10.1007\/s11033-023-08689-7","volume":"50","author":"L Schwarzova","year":"2023","unstructured":"Schwarzova L, Varchulova Novakova Z, Danisovic L, Ziaran S. Molecular classification of urothelial bladder carcinoma. Mol Biol Rep. 2023;50(9):7867\u201377.","journal-title":"Mol Biol Rep"},{"issue":"5","key":"725_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020. Cancer J Clin. 2020;70(5):404\u201323.","journal-title":"Cancer J Clin"},{"issue":"12","key":"725_CR4","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1002\/cncr.30588","volume":"123","author":"TA Berman","year":"2017","unstructured":"Berman TA, Schiller JT. Human papillomavirus in cervical cancer and oropharyngeal cancer: one cause, two diseases. Cancer. 2017;123(12):2219\u201329.","journal-title":"Cancer"},{"issue":"10","key":"725_CR5","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.3390\/v13101892","volume":"13","author":"O Basukala","year":"2021","unstructured":"Basukala O, Banks L. The not-so-good, the bad and the ugly: HPV E5, E6 and E7 oncoproteins in the orchestration of carcinogenesis. Viruses. 2021;13(10):1892.","journal-title":"Viruses"},{"key":"725_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13027-020-00318-3","volume":"15","author":"S Ohadian Moghadam","year":"2020","unstructured":"Ohadian Moghadam S, Mansori K, Nowroozi MR, Afshar D, Abbasi B, Nowroozi A. Association of human papilloma virus (HPV) infection with oncological outcomes in urothelial bladder cancer. Infect Agents Cancer. 2020;15:1\u20138.","journal-title":"Infect Agents Cancer"},{"issue":"1","key":"725_CR7","doi-asserted-by":"publisher","first-page":"e28208","DOI":"10.1002\/jmv.28208","volume":"95","author":"JX Sun","year":"2023","unstructured":"Sun JX, Xu JZ, Liu CQ, An Y, Xu MY, Zhong XY, et al. The association between human papillomavirus and bladder cancer: evidence from meta-analysis and two\u2010sample Mendelian randomization. J Med Virol. 2023;95(1):e28208.","journal-title":"J Med Virol"},{"issue":"1","key":"725_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12301-024-00414-5","volume":"30","author":"DS Dolgasheva","year":"2024","unstructured":"Dolgasheva DS, Ibragimova MK, Tsyganov MM, Litviakov NV. Human papillomavirus and bladder cancer: literature review and meta-analysis. Afr J Urol. 2024;30(1):11.","journal-title":"Afr J Urol"},{"issue":"1","key":"725_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13027-022-00415-5","volume":"17","author":"A Khatami","year":"2022","unstructured":"Khatami A, Salavatiha Z, Razizadeh MH. Bladder cancer and human papillomavirus association: a systematic review and meta-analysis. Infect Agents Cancer. 2022;17(1):3.","journal-title":"Infect Agents Cancer"},{"issue":"7","key":"725_CR10","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3390\/diagnostics12071759","volume":"12","author":"N Muresu","year":"2022","unstructured":"Muresu N, Di Lorenzo B, Saderi L, Sechi I, Del Rio A, Piana A, Sotgiu G. Prevalence of human papilloma virus infection in bladder cancer: a systematic review. Diagnostics. 2022;12(7):1759.","journal-title":"Diagnostics"},{"issue":"9","key":"725_CR11","doi-asserted-by":"publisher","first-page":"e29088","DOI":"10.1002\/jmv.29088","volume":"95","author":"X Yao","year":"2023","unstructured":"Yao X, Xu Z, Duan C, Zhang Y, Wu X, Wu H, et al. Role of human papillomavirus and associated viruses in bladder cancer: an updated review. J Med Virol. 2023;95(9):e29088.","journal-title":"J Med Virol"},{"issue":"10","key":"725_CR12","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1002\/jmv.21554","volume":"81","author":"A Damay","year":"2009","unstructured":"Damay A, Didelot-Rousseau MN, Costes V, Konate I, Ouedraogo A, Nagot N, et al. Viral load and physical status of human papillomavirus (HPV) 18 in cervical samples from female sex workers infected with HPV 18 in Burkina Faso. J Med Virol. 2009;81(10):1786\u201391.","journal-title":"J Med Virol"},{"issue":"1","key":"725_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1756-8722-5-25","volume":"5","author":"M Imajoh","year":"2012","unstructured":"Imajoh M, Hashida Y, Taniguchi A, Kamioka M, Daibata M. Novel human polyomaviruses, Merkel cell polyomavirus and human polyomavirus 9, in Japanese chronic lymphocytic leukemia cases. J Hematol Oncol. 2012;5(1):25.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"725_CR14","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1128\/JCM.40.3.886-891.2002","volume":"40","author":"P Peitsaro","year":"2002","unstructured":"Peitsaro P, Johansson B, Syrj\u00e4nen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol. 2002;40(3):886\u201391.","journal-title":"J Clin Microbiol"},{"key":"725_CR15","doi-asserted-by":"crossref","unstructured":"Das S, Kundu M, Jena BC, Mandal M. Causes of cancer: physical, chemical, biological carcinogens, and viruses. In: Biomaterials for 3D tumor modeling. Elsevier; 2020. p. 607\u201341.","DOI":"10.1016\/B978-0-12-818128-7.00025-3"},{"issue":"6","key":"725_CR16","doi-asserted-by":"publisher","first-page":"e29741","DOI":"10.1002\/jmv.29741","volume":"96","author":"SF Fobian","year":"2024","unstructured":"Fobian SF, Mei X, Crezee J, Snoek BC, Steenbergen RD, Hu J, et al. Increased human papillomavirus viral load is correlated to higher severity of cervical disease and poorer clinical outcome: A systematic review. J Med Virol. 2024;96(6):e29741.","journal-title":"J Med Virol"},{"key":"725_CR17","doi-asserted-by":"publisher","first-page":"107670","DOI":"10.1016\/j.pharmthera.2020.107670","volume":"218","author":"A Fishbein","year":"2021","unstructured":"Fishbein A, Hammock BD, Serhan CN, Panigrahy D, Carcinogenesis. Fail Resolution inflammation? Pharmacol Ther. 2021;218:107670.","journal-title":"Fail Resolution inflammation? Pharmacol Ther"},{"issue":"8","key":"725_CR18","doi-asserted-by":"publisher","first-page":"930","DOI":"10.5858\/2003-127-930-HPEAPH","volume":"127","author":"M Schiffman","year":"2003","unstructured":"Schiffman M, Castle PE. Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med. 2003;127(8):930\u20134.","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"725_CR19","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/bjc.2011.519","volume":"106","author":"J Polesel","year":"2012","unstructured":"Polesel J, Gheit T, Talamini R, Shahzad N, Lenardon O, Sylla B, et al. Urinary human polyomavirus and papillomavirus infection and bladder cancer risk. Br J Cancer. 2012;106(1):222\u20136.","journal-title":"Br J Cancer"},{"key":"725_CR20","first-page":"355","volume":"6","author":"G Eslami","year":"2008","unstructured":"Eslami G, Golshani M, Rakhshon M, Fallah F, Goudarzi H. The study on relation of human papillomavirus with bladder transitional cell carcinoma. Cancer Therapy. 2008;6:355\u201360.","journal-title":"Cancer Therapy"},{"issue":"1","key":"725_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.euf.2014.11.001","volume":"1","author":"M Rink","year":"2015","unstructured":"Rink M, Crivelli JJ, Shariat SF, Chun FK, Messing EM, Soloway MS. Smoking and bladder cancer: a systematic review of risk and outcomes. Eur Urol Focus. 2015;1(1):17\u201327.","journal-title":"Eur Urol Focus"},{"issue":"1","key":"725_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1080\/21645515.2018.1512453","volume":"15","author":"J Hirth","year":"2019","unstructured":"Hirth J. Disparities in HPV vaccination rates and HPV prevalence in the united states: a review of the literature. Hum Vaccines Immunotherapeutics. 2019;15(1):146\u201355.","journal-title":"Hum Vaccines Immunotherapeutics"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-025-00725-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-025-00725-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-025-00725-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:39:59Z","timestamp":1781624399000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13027-025-00725-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["725"],"URL":"https:\/\/doi.org\/10.1186\/s13027-025-00725-4","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"19 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards and informed consent was obtained. This project was approved by the Ethics Committee of Babol University of Medical Sciences (Ethics code: IR.MUBABOL.HRI.REC.1402.053).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}